Unfortunately, selective inhibition of MTH1 in lung cancer cells showed increased oxidative DNA damage which indicates that MTH1 inhibition will likely not be utilized as an across-the-board therapeutic strategy [137]. This evidence concerns the gene NUDT1 and lung cancer.